Hetzel W
Pharma Clinical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Psychopharmacology (Berl). 1992;106 Suppl:S127-9. doi: 10.1007/BF02246256.
Moclobemide is a reversible inhibitor of the monoamine oxidase type A. In clinical studies, more than 3900 patients have been treated with moclobemide for depression. Eighteen of these patients attempted suicide by overdosing moclobemide with or without other drugs. All patients recovered fully without leaving signs of cardio- or hepatotoxicity. Moclobemide can safely be prescribed for in- and out-patient treatment of depression.
吗氯贝胺是一种可逆性单胺氧化酶 A 型抑制剂。在临床研究中,超过3900名患者接受了吗氯贝胺治疗抑郁症。其中18名患者通过过量服用吗氯贝胺(无论是否同时服用其他药物)试图自杀。所有患者均完全康复,未留下心脏或肝脏毒性迹象。吗氯贝胺可安全地用于抑郁症的门诊和住院治疗。